ENDOTHELIAL DYSFUNCTION AND A LOW SALT DIET

内皮功能障碍和低盐饮食

基本信息

  • 批准号:
    7132464
  • 负责人:
  • 金额:
    $ 42.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-23 至 2007-04-08
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Recent evidence suggests that there is an increase in superoxide production due to activation of the angiotensin II type 1 receptor and that the superoxide comes from the NADPH oxidase. This superoxide contributes to the biological effects of angiotensin II in that a portion of the hypertension during chronic angiotensin II infusion is superoxide dependent. The hypertension to angiotensin II is at least in part due to the scavenging of nitric oxide by superoxide. Thus, the link between the generation of superoxide and the reduction in the biological effects of NO has already been established. Our recent studies suggest that the regulation of cardiac metabolism, oxygen consumption and substrate uptake, is one of the important actions of NO and that this may not only be important in the regulation of cardiac efficiency in physiologic states, such as exercise and pregnancy, but that in disease states where NO is scavenged by superoxide, the decreased bioactivity of NO may contribute to the disease process. Interestingly, one of the initial biologic actions of angiotensin II was the control of blood volume, since angiotensin II promotes sodium reabsorption especially in states where salt intake is limited. Thus plasma angiotensin II levels increase in patients and experimental animals on a salt restricted diet. If a rise in plasma angiotensin II increases superoxide production and inactivates NO, and if plasma angiotensin II levels increase during low salt diet, then does a low salt diet result in a hitherto undescribed endothelial dysfunction and to alterations in cardiac metabolism? Thus we hypothesize that low salt diet results in endothelial dysfunction characterized by altered cardiac metabolism and coronary blood flow regulation subsequent to reduced NO bioactivity that is angiotensin II and superoxide dependent. In specific aim 1 we will use rats to determine changes in renal function, plasma angiotensin II, cardiac metabolism and the role of the NADPH oxidase during low salt intake. Aim 2 will use the gp91phox KO -/- and p47 -/- mouse heart to further elucidate the relationship between angiotensin II, the NADPH oxidase and NO in the control of cardiac metabolism. We will use chronically instrumented conscious dogs to determine the time course and biological basis for alterations in cardiac metabolism, specific aim 3, and in cardiac substrate oxidation and metabolic gene expression, specific aim 4, during restricted salt intake reduction in NO bioactivity. We will examine the mechanism of potential endothelial dysfunction due to acute salt depletion using a diuretic. Interestingly, patients on a low salt diet may have an increase in cardiac events compared to those on normal salt intake, ie. events are inversely proportional to salt intake. Almost counter intuitively, it seems that patients on a low salt diet have a reduction in cardiac events when salt intake is increased. Thus our studies will examine the relationship between restricted salt intake and endothelial dysfunction with special reference to the role of altered NO bioactivity due to superoxide generation by the NADPH oxidase.
描述(由申请人提供):最近的证据表明,由于血管紧张素II型1受体的激活,超氧化物的产生增加,并且超氧化物来自NADPH氧化酶。这种超氧化物有助于血管紧张素II的生物学效应,因为慢性血管紧张素II输注期间高血压的一部分是超氧化物依赖的。高血压对血管紧张素II的影响至少部分是由于超氧化物对一氧化氮的清除。因此,超氧化物的产生与一氧化氮生物效应的降低之间的联系已经确立。我们最近的研究表明,心脏代谢、氧气消耗和底物摄取的调节是NO的重要作用之一,这可能不仅在生理状态下(如运动和怀孕)对心脏效率的调节中起重要作用,而且在NO被超氧化物清除的疾病状态下,NO生物活性的降低可能有助于疾病过程。有趣的是,血管紧张素II最初的生物作用之一是控制血容量,因为血管紧张素II促进钠的再吸收,特别是在盐摄入量有限的状态下。因此,限盐饮食的患者和实验动物血浆血管紧张素II水平升高。如果血浆血管紧张素II的升高增加了超氧化物的产生并使NO失活,并且如果低盐饮食期间血浆血管紧张素II水平升高,那么低盐饮食是否会导致迄今尚未描述的内皮功能障碍和心脏代谢的改变?因此,我们假设低盐饮食导致内皮功能障碍,其特征是心脏代谢和冠状动脉血流调节的改变,随后是血管紧张素II和超氧化物依赖的NO生物活性降低。在具体目标1中,我们将使用大鼠来确定低盐摄入期间肾功能、血浆血管紧张素II、心脏代谢和NADPH氧化酶的作用的变化。Aim 2将利用gp91phox KO -/-和p47 -/-小鼠心脏进一步阐明血管紧张素II、NADPH氧化酶和NO在心脏代谢控制中的关系。我们将使用长期仪器的有意识狗来确定在限制盐摄入降低NO生物活性期间心脏代谢(特异性目标3)和心脏底物氧化和代谢基因表达(特异性目标4)变化的时间过程和生物学基础。我们将使用利尿剂检查急性盐消耗引起的潜在内皮功能障碍的机制。有趣的是,与正常盐摄入量的患者相比,低盐饮食的患者可能会增加心脏事件。事件与盐摄入量成反比。几乎与直觉相反的是,当盐摄入量增加时,低盐饮食的患者似乎会减少心脏事件。因此,我们的研究将探讨限制盐摄入与内皮功能障碍之间的关系,特别涉及NADPH氧化酶产生超氧化物导致NO生物活性改变的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas H HINTZE其他文献

Thomas H HINTZE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas H HINTZE', 18)}}的其他基金

Coronary to Myocyte Signaling
冠状动脉至心肌细胞信号传导
  • 批准号:
    7252867
  • 财政年份:
    2007
  • 资助金额:
    $ 42.36万
  • 项目类别:
CORONARY TO MYOCYTE SIGNALING
冠状动脉至心肌细胞信号传导
  • 批准号:
    6931015
  • 财政年份:
    2004
  • 资助金额:
    $ 42.36万
  • 项目类别:
VASCULAR REGULATION BY FLOW VELOCITY/ENDOTHELIUM
通过流速/内皮调节血管
  • 批准号:
    6316702
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:
CONTROL OF NO BY EXERCISE & INSULIN IN DIABETIC HEART
通过运动控制“不”
  • 批准号:
    6498973
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    7211369
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    6929997
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    7393134
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:
CONTROL OF NO BY EXERCISE & INSULIN IN DIABETIC HEART
通过运动控制“不”
  • 批准号:
    6044504
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:
CONTROL OF NO BY EXERCISE & INSULIN IN DIABETIC HEART
通过运动控制“不”
  • 批准号:
    6351541
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    7023880
  • 财政年份:
    2000
  • 资助金额:
    $ 42.36万
  • 项目类别:

相似海外基金

Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
  • 批准号:
    493141
  • 财政年份:
    2023
  • 资助金额:
    $ 42.36万
  • 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
  • 批准号:
    10734120
  • 财政年份:
    2023
  • 资助金额:
    $ 42.36万
  • 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10707997
  • 财政年份:
    2022
  • 资助金额:
    $ 42.36万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2022
  • 资助金额:
    $ 42.36万
  • 项目类别:
    Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10555926
  • 财政年份:
    2022
  • 资助金额:
    $ 42.36万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2021
  • 资助金额:
    $ 42.36万
  • 项目类别:
    Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
  • 批准号:
    445961
  • 财政年份:
    2021
  • 资助金额:
    $ 42.36万
  • 项目类别:
    Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
  • 批准号:
    10164776
  • 财政年份:
    2020
  • 资助金额:
    $ 42.36万
  • 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
  • 批准号:
    10251271
  • 财政年份:
    2020
  • 资助金额:
    $ 42.36万
  • 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
  • 批准号:
    20K09284
  • 财政年份:
    2020
  • 资助金额:
    $ 42.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了